167 filings
8-K
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
20 Jun 24
Departure of Directors or Certain Officers
4:10pm
8-K
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
9 May 24
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
7:09am
8-K
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
15 Feb 24
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
7:04am
8-K
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
8 Jan 24
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
6:05am
8-K
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
9 Nov 23
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
7:07am
8-K/A
f6gedr7ibvlopj7ri4
11 Sep 23
Index to Financial Statements
4:30pm
8-K
umao5pbk2l6d gcw
8 Aug 23
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
7:08am
8-K
ev66hed
30 Jun 23
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
4:05pm
8-K
xcp4r3tkr8u xq02w5h
22 Jun 23
Departure of Directors or Certain Officers
4:08pm
8-K
b8g04sqgvgpexof
22 May 23
Entry into a Material Definitive Agreement
4:25pm
8-K
xctts3426h
4 May 23
Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance
7:12am
8-K
rxv5xbhojczxfx
11 Apr 23
Departure of Directors or Certain Officers
8:30am
8-K
j64lum t4dx
16 Feb 23
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results
7:09am
8-K
s09 tyag4m2
9 Jan 23
Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance
6:30am
8-K
28qfo6a
3 Nov 22
Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
7:00am
8-K
c88dr3n9w146tpyy0g
4 Aug 22
Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
7:06am
8-K
b01mm
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
7j8 7rf1h1zdjwpkqd
5 May 22
Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
7:07am
8-K
apwsj5adjx88t
17 Feb 22
Results of Operations and Financial Condition
7:06am
8-K
3vvv8 b2da8
10 Jan 22
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
7:33am